From professional translators, enterprises, web pages and freely available translation repositories.
ast or alt > 8 x uln or
ast o alt > 8 x lsn o
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
patients with baseline values of hepatic aminotransferases (ast and/or alt) 3x uln.
valores basales de aminotransferasas hepáticas (ast y/o alt) 3x uln.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
increased transaminases (ast and/or alt)1
aumento de transaminasas (ast y/o alt)1
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ctrl+f4 or alt+f4
(ctrl)(f4) o (alt)(f4)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
elevation of ast and/or alt values to > 5 x uln
aumento de los valores de ast y/o alt a > 5 x lsn
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
increased transaminases (ast and/or alt)1, 2, 3
aumento de las transaminasas (ast y/o alt)1, 2, 3
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
elevations of ast and/or alt are associated with sitaxentan sodium.
el uso de sitaxentan sódico se asocia con niveles elevados de ast y/o alt.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
abnormal tests of liver function, elevated ast and/ or alt liver enzymes
tests anormales de la función hepática; aumento de asat, aumento de alat.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
in case of liver metastasis with baseline grade 2 elevation of ast or alt, hepatitis with ast or alt increases ≥ 50% and lasts ≥ 1 week
en caso de metástasis hepática en estado basal con elevación de grado 2 de la ast o la alt, hepatitis con la ast o la alt elevadas ≥ 50% y ésta dura ≥ 1 semana
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
should an increase in ast or alt of 3x uln or greater persist, withdrawal of galvus therapy is recommended.
en caso de que persistan aumentos de 3 veces el límite superior de la normalidad (lsn) de ast o alt o aumentos mayores, se recomienda interrumpir el tratamiento con galvus.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
should an increase in ast or in alt of 3x uln or greater persist, withdrawal of eucreas therapy is recommended.
en caso de que persistan aumentos de 3 veces el límite superior de la normalidad (lsn) de ast o alt o aumentos mayores, se recomienda interrumpir el tratamiento con eucreas.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
to get them to accord with delta t (or alt t) ecology
para conseguirlos a que acuerden con la ecología delta t (o alt t)
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
rare cases of moderate increases in ast and/or alt have been reported where a causal relationship to raloxifene can not be excluded.
se han notificado casos raros de incrementos moderados de la ast y/o alt en los que no se puede descartar una relación causal con raloxifeno.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
table 2: recommended dose adjustments for vargatef (nintedanib) in case of ast and/or alt and bilirubin elevations
tabla 2: ajustes de la dosis recomendados para vargatef (nintedanib) en el caso de aumentos en los niveles de ast y/o alt y bilirrubina
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
elevations of ast and/or alt associated with thelin occur both early and late in treatment, usually progress slowly, and are typically asymptomatic.
niveles elevados de ast y/o alt asociados a thelin ocurren temprano y tarde en el tratamiento, avanzan normalmente despacio y son típicamente asintomáticos.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
contraindication in patients with severe hepatic impairment (with or without cirrhosis) and in patients with baseline values of hepatic aminotransferases (ast and/or alt) >3x uln.
contraindicación en pacientes con insuficiencia hepática grave (con o sin cirrosis) en pacientes con valores basales de aminotransferasas hepáticas (ast y/o alt) > 3x lsn.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
for patients with confirmed elevations in alt, ast or bilirubin during treatment, the following dose adjustments may be necessary.
en pacientes con elevaciones confirmadas de alt, ast o bilirrubina durante el tratamiento, puede que haya que realizar los siguientes ajustes de la dosis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
if ast and/or alt are above 3 x uln prior to initiation of therapy, use of thelin is contraindicated (see section 4.3) .
si ast y/o alt están por encima de 3 x uln antes del inicio de la terapia, el uso de thelin está contraindicado (ver sección 4.3) .
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
elevations in liver aminotransferases, i.e., aspartate and alanine aminotransferases (ast and/or alt), associated with bosentan are dose dependent.
la elevación de los valores de aminotransferasas hepáticas, es decir, aspartato aminotransferasa y alanina aminotransferasa (ast y/o alt), asociada con bosentan, es dosis-dependiente.
Last Update: 2017-04-26
Usage Frequency: 7
Quality: